FDA Names Frueh Head Of Pharmacogenomics Review Group
This article was originally published in The Pink Sheet Daily
Executive Summary
Felix Frueh, PhD, is associate director of genomics in CDER’s Office of Clinical Pharmacology & Biopharmaceutics and head of FDA’s new Interdisciplinary Pharmacogenomics Review Group. The agency continues to recruit staff for the IPRG.
You may also be interested in...
Pharmacogenomics Public Workshop Planned For April 2005
The meeting will follow release of an FDA draft guidance on the co-development of pharmacogenomic tests with a drug or biologic, which is expected by the end of the year.
Merck Tax Settlement Could Be Smaller Than GSK’s $3.4 Bil. IRS Deal
A possible settlement between Merck and tax authorities could be significantly smaller than GlaxoSmithKline's recent settlement with the IRS based on the companies' projected liability
McKindler? New Pfizer CEO Echoes McKinnell’s Views On Payers, Scale
Pfizer's success will depend on its ability to negotiate the paradox of increasing demand for pharmaceuticals coupled with growing attempts to restrain costs, CEO Jeffrey Kindler said